EN

What should I ask my doctor about GLP-1 medicines?

Answer a few questions and get a printable visit sheet for your family doctor, nurse practitioner, specialist or pharmacist: what to bring, questions for your situation, how to check an online clinic, and when to call 9-1-1.

Takes about 2 minutes Nothing you type leaves your device Every question cites its source
Step 1 of 9Who it's for
Who is this visit sheet for?

We'll write the sheet in the right voice: "my" for you, "their" for someone else.

Age (optional)
Sex (optional; sets the pregnancy questions)
Province or territory (optional; drug coverage differs)
What's the main reason for the visit?

Pick the closest one. It changes which questions come first.

Do you have any of these health conditions?

Check any that apply and skip the rest. Each one you check adds a question for the doctor to your sheet.

Linked to weight or sugar
Need extra care with these medicines
Personal or family history
Which medicines do you take now?

Some of these change what the prescriber needs to plan. Tick all that apply.

Could you be pregnant, or are you planning a baby?

These medicines aren't used in pregnancy, and one affects the pill. This step is skipped if you chose "Man".

Which tests have you had in the last 3 months?

Tick the ones with a result you can show, for example on a printout or in an app. The sheet asks about the rest.

What worries you most?

Pick as many as you like. Each adds a sourced question.

Height, weight and waist

Optional. If you add them, the sheet shows BMI against the Obesity Canada cut-offs, and your waist against the cut-offs for women and men. Skip this if you'd rather be measured at the appointment.

Height
Weight
Waist (halfway between your lowest rib and the top of your hip bone, after breathing out)
Ethnic background (optional; sets which Obesity Canada cut-offs apply)
Anything else the prescriber should know?

Optional. For example: past attempts at losing weight, side effects so far, or a surgery date. It goes into the "About" box, and you can edit it on the sheet too.

Next, you'll see the sheet. You can tick items, edit any line, add your own questions, then print it, save it as a PDF or email it to yourself.

Private by design: the sheet is built in your browser. Nothing is sent or stored unless you choose to email it to yourself, and nothing goes in the link. Privacy notice

Your visit sheet is ready

Tap any line in "About" or any question to change the words. Remove questions with ×, or add your own. Ticks print too.

What this means

What this doesn't mean

  • It isn't a yes or a no. No tool can tell whether a GLP-1 medicine suits someone. A prescriber decides that after a history, a check-up and tests.
  • It isn't every question. It covers the common ones and those your answers point to. Your doctor may ask about things not listed here.
  • Don't change any medicine on your own. The dose questions are for the prescriber to answer, not for you to act on before the visit.

Why each question is on your sheet

The rule behind each question for your situation, with its source. The numbers match the sources at the foot of the sheet. All checked 12 Oct 2026.

    Read before the visit

    How this works

    You answer up to 9 short questions. Only the first one is needed. The tool then picks questions from a fixed list, and every question is tied to a source: a Health Canada product monograph or a US label, a Health Canada advisory, Obesity Canada guidance, or a provincial college's rules.2,3,7,5,6

    Eight core questions go on every sheet. Your answers add more. For example, insulin or a sulfonylurea (such as gliclazide) adds a question about low blood sugar, because the Ozempic label warns about low sugar (hypos) with that mix.3

    If you add height and weight, the sheet shows BMI against the Obesity Canada cut-offs, including the lower ones for South, Southeast and East Asian adults. A waist measurement is compared with the cut-offs for women and men.1 These numbers describe weight. They are not a threshold for medicine.

    The "Check your provider" box uses Health Canada's advice on fake GLP-1s and the Ontario college's virtual care policy.7,6 The red box lists the symptoms that need 9-1-1, and how to report a side effect to Health Canada.11,8

    What this can't tell you

    • Whether a GLP-1 medicine suits you, or which one. That's for a prescriber who has checked you.
    • Anything about your dose. The tool never suggests one.
    • Whether your provincial plan or private insurance will pay. Public plans cover semaglutide for type 2 diabetes with criteria, and each plan sets its own rules.10

    Questions people ask

    Is anything I type saved or sent anywhere?

    No. The sheet is built inside your browser. Nothing you type is sent to us or stored, and there is no link that contains your answers. Only if you choose "Email it to me" do we pass the sheet and your address to our email service once, to deliver it.

    Can I make a sheet for my mother or father?

    Yes. Choose "A family member" on the first screen and the sheet is written about them.

    Can a pharmacist prescribe a GLP-1 in Canada?

    It depends on the province. In Alberta, pharmacists with Additional Prescribing Authorization can prescribe at first access, manage ongoing care or stop a medicine; about two in three clinical pharmacists there held it at the end of 2025.14 Rules elsewhere differ, so ask your pharmacist.

    Is Mounjaro approved for weight loss in Canada?

    No. In Canada, Mounjaro is approved for type 2 diabetes.13 Tirzepatide for weight management is sold as Zepbound, approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition.12

    Why does it ask about the birth control pill?

    Tirzepatide (Mounjaro, Zepbound) can make the pill less reliable. Its US label advises a non-pill method, or adding a barrier method such as condoms, for 4 weeks after starting and for 4 weeks after each dose increase.4

    I'm already taking a GLP-1. Is this useful for me?

    Yes. Choose "Already taking one" and the sheet becomes a review: who prescribed it and how they checked you, your dose, whether your pen could be fake or recalled, and whether it's working well enough to continue.6,7,9

    How do I report a side effect?

    Report it to Health Canada's Canada Vigilance Program, online or by phone at 1-866-234-2345. Anyone can report a side effect, including patients and family members.8

    Sources

    1. Obesity Canada. Canadian Adult Obesity Clinical Practice Guideline: Assessment of people living with obesity, Version 1, 4 August 2020 (BMI and waist cut-offs, including the Asian cut-offs). obesitycanada.ca. Checked 12 Oct 2026.
    2. Novo Nordisk Canada. Wegovy product monograph, 2 October 2026 (Health Canada Drug Product Database). pdf.hres.ca. Checked 12 Oct 2026.
    3. Novo Nordisk. Ozempic (semaglutide) US prescribing information, revised May 2026: sections 5, 7, 8.3. PDF. Checked 12 Oct 2026.
    4. Eli Lilly. Mounjaro (tirzepatide) US prescribing information, revised August 2026: section 7 (oral contraceptives). PDF. Checked 12 Oct 2026.
    5. Obesity Canada. Canadian Adult Obesity Clinical Practice Guideline: Pharmacotherapy for obesity management, 2025 update (Version 3, 11 August 2025). obesitycanada.ca. Checked 12 Oct 2026.
    6. College of Physicians and Surgeons of Ontario. Virtual Care policy, updated June 2022. cpso.on.ca. Checked 12 Oct 2026.
    7. Health Canada. Advisory RA-81518: thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products, updated 21 January 2026. recalls-rappels.canada.ca. Checked 12 Oct 2026.
    8. Health Canada. Adverse reaction reporting: Canada Vigilance Program (online, phone 1-866-234-2345, fax or mail). canada.ca. Checked 12 Oct 2026.
    9. Health Canada. Recall: semaglutide injection (Dr. Reddy's), impurity out of specification, 27 August 2026. recalls-rappels.canada.ca. Checked 12 Oct 2026.
    10. Ontario Ministry of Health. Ontario Drug Benefit Formulary: semaglutide (Limited Use). formulary.health.gov.on.ca. Checked 12 Oct 2026.
    11. CRTC. 9-1-1 emergency services. crtc.gc.ca. Checked 12 Oct 2026.
    12. Eli Lilly Canada. Zepbound product monograph, 11 June 2026: weight management and obstructive sleep apnea in adults. pdf.hres.ca. Checked 12 Oct 2026.
    13. Eli Lilly Canada. Mounjaro product monograph, 23 June 2026: type 2 diabetes. pdf.hres.ca. Checked 12 Oct 2026.
    14. Alberta College of Pharmacy. Additional prescribing authorization matters for safe pharmacy practice in Alberta, 24 February 2026 (66% of clinical pharmacists held it on 31 December 2025). abpharmacy.ca. Checked 12 Oct 2026.

    The sheet itself cites up to 30 more sources, listed at its foot. Last checked 12 Oct 2026 · Next review due Jan 2027

    How this tool was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical advice. Talk to your doctor, nurse practitioner or pharmacist before starting, stopping or changing any medicine. In an emergency, call 9-1-1. How we write